CorMedix Inc CRMD
7.85
0.08
1.03%
as of 25 Sep
- Market cap
- $608.0M
- P/E
- 3.3×
Follow CRMD
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
75.08% | 66.56% | 65.59% | 54.93% | |
| 39.23% | 34.51% | 37.51% | 32.36% | ||
ROIC |
14.02% | 23.38% | 29.97% | 38.84% | |
Return on Tangible Assets |
124.77% | 82.04% | 69.49% | 62.18% | |
Average Days of Receivables |
270.08 | 200.51 | 141.24 | 127.37 | |
Free Cash Flow per Share |
0.98 | 2.40 | 2.45 | 3.19 | |
Free Cash Flow |
74.42 | 172.79 | 194.71 | 250.42 | |
Capital Expenditures |
(0.55) | (2.26) | (2.98) | (3.52) | |
Piotroski F-Score |
5.00 | 5.00 | 5.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
13.04% | 25.06% | 26.01% | 29.44% | |
Accounts Receivable Turnover |
2.44 | 2.80 | 3.82 | 4.53 | |
Accounts Payable Turnover |
1.45 | 7.49 | 7.68 | 9.92 | |
Inventory Turnover |
0.89 | 1.93 | 2.97 | 3.30 | |
Average Days of Payables |
471.67 | 80.02 | 82.62 | 46.94 | |
Days of Inventory on Hand |
666.80 | 301.61 | 197.94 | 176.89 | |
Tax Rate |
0.53 | 0.09 | (0.02) | (0.08) | |
Research and Development Expense of Revenue |
5.81% | 6.20% | 5.84% | 5.97% | |
Selling, General and Administrative Expense of Revenue |
38.29% | 34.09% | 31.59% | 29.85% | |
Share Based Compensation of Revenue |
5.34% | 4.44% | 3.73% | 3.53% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.46 | 1.07 | 1.09 | 1.36 | |
Depreciation/Fixed assets |
1.03 | 2.58 | 4.18 | 4.60 | |
Capex/Depreciation |
(0.12) | (0.15) | (0.12) | (0.10) | |
Revenue per Share |
2.82 | 4.33 | 5.03 | 5.89 | |
Operating CF per Share |
0.99 | 2.43 | 2.49 | 3.24 | |
Capex per Share |
(0.01) | (0.03) | (0.04) | (0.04) | |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
75.83% | 52.31% | 45.25% | 40.49% |
Columns are period end dates